stella
beta
ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer — Stella
Recruiting
Back to Small Cell Lung Cancer trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Trial locations
(9 sites)
China
Beijing Cancer Hospital, Beijing, Beijing Municipality
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Henan Cancer Hospital, Zhengzhou, Henan
Jilin Cancer Hospital, Changchun, Jilin
Shengjing Hospital of China Medical University, Shenyang, Liaoning
Show all 9 locations
View full record on ClinicalTrials.gov